Pharmacogenomics of Depression

Michael Maes, Eugène Bosmans, Herbert Y Meltzer, Simon Scharpé, Eduard Suy, Interleukin-1 beta: a putative mediator of HPA axis hyperactivity in major depression? American Journal of Psychiatry. ,vol. 150, pp. 1189- 1193 ,(1993) , 10.1176/AJP.150.8.1189

Martin Preisig, Fran??ois Ferrero, Alain Malafosse, Monoamine Oxidase A and Tryptophan Hydroxylase Gene Polymorphisms American Journal of Pharmacogenomics. ,vol. 5, pp. 45- 52 ,(2005) , 10.2165/00129785-200505010-00004

Alessandro Serretti, Raffaella Calati, Osmano Oasi, Diana De Ronchi, Cristina Colombo, Dissecting the determinants of depressive disorders outcome: an in depth analysis of two clinical cases. Annals of General Psychiatry. ,vol. 6, pp. 5- 5 ,(2007) , 10.1186/1744-859X-6-5

Leif Bertilsson, Marja-Liisa Dahl, Per Dalén, Ayman Al-Shurbaji, Molecular genetics of CYP2D6: Clinical relevance with focus on psychotropic drugs British Journal of Clinical Pharmacology. ,vol. 53, pp. 111- 122 ,(2002) , 10.1046/J.0306-5251.2001.01548.X

Kim Smits, Luc Smits, Frenk Peeters, Jan Schouten, Rob Janssen, Hubert Smeets, Jim van Os, Martin Prins, Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors. International Clinical Psychopharmacology. ,vol. 22, pp. 137- 143 ,(2007) , 10.1097/YIC.0B013E328014822A

Eric P. Zorrilla, Lester Luborsky, James R. McKay, Robert Rosenthal, Arlene Houldin, Anne Tax, Ruth McCorkle, David A. Seligman, Kelly Schmidt, The Relationship of Depression and Stressors to Immunological Assays: A Meta-Analytic Review Brain Behavior and Immunity. ,vol. 15, pp. 199- 226 ,(2001) , 10.1006/BRBI.2000.0597

Zhifeng Zhou, Alec Roy, Robert Lipsky, Kavi Kuchipudi, Guanshan Zhu, Julie Taubman, Mary-Anne Enoch, Matti Virkkunen, David Goldman, Haplotype-Based Linkage of Tryptophan Hydroxylase 2 to Suicide Attempt, Major Depression, and Cerebrospinal Fluid 5-Hydroxyindoleacetic Acid in 4 Populations Archives of General Psychiatry. ,vol. 62, pp. 1109- 1118 ,(2005) , 10.1001/ARCHPSYC.62.10.1109

A Szegedi, D Rujescu, A Tadic, M J Müller, R Kohnen, H H Stassen, N Dahmen, The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenomics Journal. ,vol. 5, pp. 49- 53 ,(2005) , 10.1038/SJ.TPJ.6500289

Alessandro Serretti, Laura Mandelli, Cristina Lorenzi, Adele Pirovano, Paolo Olgiati, Cristina Colombo, Enrico Smeraldi, Serotonin transporter gene influences the time course of improvement of "core" depressive and somatic anxiety symptoms during treatment with SSRIs for recurrent mood disorders. Psychiatry Research-neuroimaging. ,vol. 149, pp. 185- 193 ,(2007) , 10.1016/J.PSYCHRES.2006.03.020

S Fuke, S Suo, N Takahashi, H Koike, N Sasagawa, S Ishiura, The VNTR polymorphism of the human dopamine transporter (DAT1) gene affects gene expression. Pharmacogenomics Journal. ,vol. 1, pp. 152- 156 ,(2001) , 10.1038/SJ.TPJ.6500026